Results 1 to 10 of about 755,229 (351)

Study on the approach to scoliosis in children of age prepuberty [PDF]

Annals of the “Ştefan cel Mare” University: Physical Education and Sport Section - The Science and Art of Movement, 2023
This paper aims to present some of the usual aspects that accompany the processes of installation and development of scoliotic attitudes in prepubertal children.
Mihai Constantinescu
doaj   +1 more source

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.

New England Journal of Medicine, 2023
BACKGROUND In patients undergoing allogeneic hematopoietic stem-cell transplantation (HSCT), a calcineurin inhibitor plus methotrexate has been a standard prophylaxis against graft-versus-host disease (GVHD).
J. Bolaños-Meade, M. Hamadani, Juan Wu, M. A. Al Malki, M. Martens, L. Runaas, H. Elmariah, Andrew R. Rezvani, Mahasweta Gooptu, Karilyn T. Larkin, B. Shaffer, Najla El Jurdi, A. Loren, M. Solh, Aric Hall, A. Alousi, Omer H Jamy, M. Perales, Janny M. Yao, Kristy Applegate, Ami S. Bhatt, L. Kean, Y. Efebera, R. Reshef, W. Clark, N. Difronzo, E. Leifer, M. Horowitz, Richard J. Jones, S. Holtan   +29 more
semanticscholar   +1 more source

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

The Lancet Oncology, 2022
The International Initiative on Thrombosis and Cancer is an independent academic working group of experts aimed at establishing global consensus for the treatment and prophylaxis of cancer-associated thrombosis.
D. Farge, C. Frère, J. Connors, A. Khorana, Ajay Kakkar, C. Ay, A. Muñoz, B. Brenner, P. Prata, D. Brilhante, D. Antić, P. Casais, M. C. Guillermo Esposito, T. Ikezoe, S. Abutalib, Luis A Meillon-García, H. Bounameaux, I. Pabinger, J. Douketis, W. Ageno, Fernando Ajauro, T. Alcindor, P. Angchaisuksiri, J. Arcelus, R. Barba, Ali Bazarbachii, A. Bellesoeur, O. Bensaoula, I. Benzidia, Darius Bita, V. Bitsadze, D. Blickstein, M. Blostein, I. Bogalho, A. Brandão, R. Calado, A. Carpentier, J. Ceresetto, R. Chitsike, J. Connault, C. Correia, B. Crichi, E. D. de Paula, A. Demir, L. Deville, L. Doucet, Vera Dounaevskaia, C. Durant, M. Ellis, J. Emmerich, A. Falanga, C. Font, E. Gallardo, T. Gary, Filipe Gonçalves, J. Gris, Hiromi Hayashi, A. Hij, L. Jara-Palomares, D. Jiménez, J. Khizroeva, Michel N'Guessan, F. Langer, C. Le Hello, C. le Maignan, R. Lecumberri, L. Lee, Z. Liederman, Luisa Lopes dos Santos, D. Machado, A. Makatsariya, Alberto Maneyro, Z. Marjanovic, Serban A. Milhaileanu, M. Monreal, Sara Morais, A. Moreira, M. Mukai, Arlette Ndour, Luciana Correa Oliveira, Remedios Otero-Candelara, Maria Carolina Tostes Pintão, F. Posch, Pascal Prilollet, Hanadi Rafii, Daniel Dias Ribeiro, H. Riess, M. Righini, H. Robert-Ebadi, C. Rothschild, A. Roussin, J. A. Rueda Camino, P. Ruiz-Artacho, G. Saharov, Joana Santos, M. Sebuhyan, A. Shamseddine, G. Spectre, A. Taher, J. Trujillo-Santos, I. Tzoran, S. Villiers, Raymond Wong, Y. Yamashita, A. Yannoutsos, Chikao Yasuda   +105 more
semanticscholar   +1 more source

Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel

Blood Cancer Journal, 2023
Bispecific antibodies (BsAbs) are emerging as an important novel class of immunotherapeutic agents for the treatment of multiple myeloma (MM), and are set to be more widely used in clinical practice.
N. Raje, K. Anderson, H. Einsele, Y. Efebera, F. Gay, S. Hammond, A. Lesokhin, S. Lonial, H. Ludwig, P. Moreau, K. Patel, K. Ramasamy, M. Mateos   +12 more
semanticscholar   +1 more source

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A.

New England Journal of Medicine, 2023
BACKGROUND Efanesoctocog alfa provides high sustained factor VIII activity by overcoming the von Willebrand factor-imposed half-life ceiling. The efficacy, safety, and pharmacokinetics of efanesoctocog alfa for prophylaxis and treatment of bleeding ...
Annette von Drygalski, P. Chowdary, R. Kulkarni, S. Susen, B. Konkle, J. Oldenburg, Davide Matino, R. Klamroth, A. Weyand, V. Jiménez‐Yuste, K. Nogami, S. Poloskey, B. Winding, A. Willemze, K. Knobe   +14 more
semanticscholar   +1 more source

Antibiotic Prophylaxis in Surgery: Current Insights and Future Directions for Surgical Site Infection Prevention

Cureus, 2023
Surgical site infections (SSIs) remain a significant concern in the field of surgery, contributing to patient morbidity, prolonged hospital stays, and increased healthcare costs.
Simran Dhole, C. Mahakalkar, Shivani Kshirsagar, Abhilasha Bhargava   +3 more
semanticscholar   +1 more source

Prophylaxie : Définition

, 2021
Appliquée aux productions végétales et animales, la prophylaxie consiste à développer et utiliser un ensemble de pratiques pour prévenir l’apparition de problèmes sanitaires, souvent d’origine multifactorielle.
Mossler, Camille, Calvignac, Lucas, Lecureur, Laure, Dayonnet, Alix, Cazemajou, Jeanne, Vidal, Arielle, Lamothe, Laurence, Savietto, Davi, Sarthou, Jean-Pierre   +8 more
openaire   +1 more source

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

New England Journal of Medicine, 2020
Background Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the standard of care is observation and quarantine.
D. Boulware, M. Pullen, A. Bangdiwala, K. Pastick, S. Lofgren, E. Okafor, C. Skipper, Alanna A Nascene, M. Nicol, M. Abassi, N. Engen, M. Cheng, Derek LaBar, S. Lother, L. MacKenzie, G. Drobot, N. Marten, R. Zarychanski, L. Kelly, Ilan S. Schwartz, E. McDonald, R. Rajasingham, T. Lee, K. H. Hullsiek   +23 more
semanticscholar   +1 more source

Durability of first-line antiretroviral treatment in the Russian Federation: retrospective study

Журнал инфектологии, 2023
Objective. To assess durability of antiretroviral therapy in first line in HIV-infected patients in real clinical practice in the Russian Federation and determine association between basic clinical and demographic characteristics and durability of ...
N. V. Sizova, Yu. K. Plotnikova, T. E. Shimonova, O. E. Chernova, E. S. Ivanova, E. S. Obizhaeva, V. F. Achikyan   +6 more
doaj   +1 more source

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.

Journal of Clinical Oncology, 2020
PURPOSE To provide updated recommendations about prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer. METHODS PubMed and the Cochrane Library were searched for randomized controlled trials (RCTs) and meta-analyses of RCTs ...
N. Key, A. Khorana, N. Kuderer, Kari Bohlke, Agnes Y. Y. Lee, J. Arcelus, S. Wong, E. Balaban, C. Flowers, C. Francis, L. Gates, A. Kakkar, M. Levine, H. Liebman, M. Tempero, G. Lyman, A. Falanga   +16 more
semanticscholar   +1 more source